Accelerating access to care: working together to improve global health
Posted by
23-Mar-2018
UCB joined policymakers, global health experts and pharma companies at the Access Accelerated event in Kenya this week.
Non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, respiratory disease, diabetes, mental health disorders and neurological conditions, are leading causes of death and disability worldwide.
Access Accelerated aims to turn the tide on a growing global health challenge. It brings together twenty-two leading pharmaceutical companies, in partnerships with the World Bank and the Union for International Cancer Control (UICC).
Participants in the Access Accelerated initiative met this week in Nairobi to discuss issues facing people with NCDs in Kenya and explore new opportunities for collaboration. Keynote speakers included representatives from the Kenya Ministry of Health and the World Bank, with break-out sessions led by the World Heart Foundation, the NCD Alliance and PATH (Program for Appropriate Technology in Health).
Access Accelerated member companies, such as UCB, displayed and shared information on NCD access initiatives in an interactive exhibition area.
At UCB, we are committed to helping people everywhere living with NCDs of the immunological and neurological systems, such as rheumatoid arthritis and epilepsy. That is why we have pledged our support to the Access Accelerated initiative which has the potential to improve the lives of millions of people in LMICs by innovation and collaboration.
A major burden
People affected by NCDs need access to prevention, treatment and quality care in a sustainable manner. NCDs account for the largest percentage of global morbidity and mortality – 70% of all deaths worldwide – causing 40 million deaths annually. NCDs are a major burden in high-income countries and will be a major challenge as populations age. In low and middle-income countries (LMICs), NCDs are projected to become the leading cause of death by 2030.
Nearly 80 percent of NCD-related deaths occur in LMICs where patients face financial, regulatory and service delivery barriers. To achieve the United Nations Sustainable Development Goal (SDG) target to reduce premature deaths from NCDs by one-third by 2030, action is needed.
As a multi-stakeholder project, Access Accelerated aims to catalyze, develop, measure and replicate sustainable programs in LMICs. It was created because we, as an industry, believe that the situation has reached a crisis point and that health structure strengthening and medicines can play a vital role in addressing it.
By building relationships, learning from one another, and working together to solve problems, we are confident to advance a holistic response to the global NCD crisis.
Non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, respiratory disease, diabetes, mental health disorders and neurological conditions, are leading causes of death and disability worldwide.
Access Accelerated aims to turn the tide on a growing global health challenge. It brings together twenty-two leading pharmaceutical companies, in partnerships with the World Bank and the Union for International Cancer Control (UICC).
Participants in the Access Accelerated initiative met this week in Nairobi to discuss issues facing people with NCDs in Kenya and explore new opportunities for collaboration. Keynote speakers included representatives from the Kenya Ministry of Health and the World Bank, with break-out sessions led by the World Heart Foundation, the NCD Alliance and PATH (Program for Appropriate Technology in Health).
Access Accelerated member companies, such as UCB, displayed and shared information on NCD access initiatives in an interactive exhibition area.
At UCB, we are committed to helping people everywhere living with NCDs of the immunological and neurological systems, such as rheumatoid arthritis and epilepsy. That is why we have pledged our support to the Access Accelerated initiative which has the potential to improve the lives of millions of people in LMICs by innovation and collaboration.
A major burden
People affected by NCDs need access to prevention, treatment and quality care in a sustainable manner. NCDs account for the largest percentage of global morbidity and mortality – 70% of all deaths worldwide – causing 40 million deaths annually. NCDs are a major burden in high-income countries and will be a major challenge as populations age. In low and middle-income countries (LMICs), NCDs are projected to become the leading cause of death by 2030.
Nearly 80 percent of NCD-related deaths occur in LMICs where patients face financial, regulatory and service delivery barriers. To achieve the United Nations Sustainable Development Goal (SDG) target to reduce premature deaths from NCDs by one-third by 2030, action is needed.
As a multi-stakeholder project, Access Accelerated aims to catalyze, develop, measure and replicate sustainable programs in LMICs. It was created because we, as an industry, believe that the situation has reached a crisis point and that health structure strengthening and medicines can play a vital role in addressing it.
By building relationships, learning from one another, and working together to solve problems, we are confident to advance a holistic response to the global NCD crisis.
Leave a Comment